Predictive Oncology Completes Acquisition of Soluble Therapeutics and BioDtech

Stock Information for Predictive Oncology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Predictive Oncology Inc.

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
Predictive Oncology to Participate in Upcoming Investor Conferences
Predictive Oncology to Participate in Upcoming San Francisco Conferences
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.